<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31526718</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>441</EndPage><MedlinePgn>425-441</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2019.09.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(19)30612-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A main pathological feature of severe dengue virus infection is endothelial hyper-permeability. The dengue virus nonstructural protein 1 (NS1) has been implicated in the vascular leakage that characterizes severe dengue virus infection, however, the molecular mechanisms involved are not known.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cohort of 250 dengue patients has been followed from the onset of symptoms to the recovery phase. Serum hyaluronan levels and several other clinical parameters were recorded. The effect of NS1 treatment of cultured fibroblasts and endothelial cells on the expressions of hyaluronan synthetic and catabolic enzymes and the hyaluronan receptor CD44, were determined, as have the effects on the formation of hyaluronan-rich matrices and endothelial permeability.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Elevated serum hyaluronan levels (&#x2265;70&#x202f;ng/ml) during early infection was found to be an independent predictor for occurrence of warning signs, and thus severe dengue fever. High circulating levels of the viral protein NS1, indicative of disease severity, correlated with high concentrations of serum hyaluronan. NS1 exposure decreased the expression of CD44 in differentiating endothelial cells impairing the integrity of vessel-like structures, and promoted the synthesis of hyaluronan in dermal fibroblasts and endothelial cells in synergy with dengue-induced pro-inflammatory mediators. Deposited hyaluronan-rich matrices around cells cultured in vitro recruited CD44-expressing macrophage-like cells, suggesting a mechanism for enhancement of inflammation. In cultured endothelial cells, perturbed hyaluronan-CD44 interactions enhanced endothelial permeability through modulation of VE-cadherin and cytoskeleton re-organization, and exacerbated the NS1-induced disruption of endothelial integrity.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Pharmacological targeting of hyaluronan biosynthesis and/or its CD44-mediated signaling may limit the life-threatening vascular leakiness during moderate-to-severe dengue virus infection. FUND: This work was supported in part by grants from the Swedish Cancer Society (2018/337; 2016/445), the Swedish Research Council (2015-02757), the Ludwig Institute for Cancer Research, Uppsala University, the Ministry of Science and Technology, Taiwan (106-2314-B-037-088- and 106-2915-I-037-501-), Kaohsiung Medical University Hospital (KMUH103-3&#x202f;T05) and Academy of Finland. The funders played no role in the design, interpretation or writing of the manuscript.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden; Division of Infectious Diseases, Department of Internal Medicine, Infection Control Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan; School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Surgical Sciences, Uppsala University, Akademiska Hospital, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolliopoulos</LastName><ForeName>Constantinos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chung-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Infection Control Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan; School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tenhunen</LastName><ForeName>Jyrki</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, Uppsala University, Akademiska Hospital, 751 85 Uppsala, Sweden; Critical Care Medicine Research Group, Department of Intensive Care, Tampere University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heldin</LastName><ForeName>Carl-Henrik</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Deparent of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, HsinChu, Taiwan. Electronic address: infchen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heldin</LastName><ForeName>Paraskevi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden. Electronic address: evi.heldin@imbim.uu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9004-61-9</RegistryNumber><NameOfSubstance UI="D006820">Hyaluronic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002199" MajorTopicYN="N">Capillary Permeability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="N">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006820" MajorTopicYN="N">Hyaluronic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD44</Keyword><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Dengue</Keyword><Keyword MajorTopicYN="N">HAS2</Keyword><Keyword MajorTopicYN="N">HYAL2</Keyword><Keyword MajorTopicYN="N">Hyaluronan</Keyword><Keyword MajorTopicYN="N">TGFbeta</Keyword><Keyword MajorTopicYN="N">VE-cadherin</Keyword><Keyword MajorTopicYN="N">Vascular leakage</Keyword></KeywordList><CoiStatement>CYL, YHC and PH have submitted a patent application based on the findings in this manuscript in United states (US 15/881,350) and EU (EP 18155997.2). CYL, YHC and PH are the inventors but not owner of a patent proved in Taiwan (TW I651535). The other authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31526718</ArticleId><ArticleId IdType="pmc">PMC6838418</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2019.09.014</ArticleId><ArticleId IdType="pii">S2352-3964(19)30612-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lennon F.E., Singleton P.A. Hyaluronan regulation of vascular integrity. Am J Cardiovasc Dis. 2011;1(3):200&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253523</ArticleId><ArticleId IdType="pubmed">22254199</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Li L., Kamiryo M., Asteriou T., Moustakas A., Yamashita H. Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J Biol Chem. 2005;280(25):24195&#x2013;24204.</Citation><ArticleIdList><ArticleId IdType="pubmed">15843382</ArticleId></ArticleIdList></Reference><Reference><Citation>West D.C., Hampson I.N., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228:1324&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pubmed">2408340</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent T.C., Hyaluronan Fraser J.R.E. FASEB J. 1992;6:2397&#x2013;2404.</Citation><ArticleIdList><ArticleId IdType="pubmed">1563592</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldin P., Lin C.Y., Kolliopoulos C., Chen Y.H., Skandalis S.S. Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production. Matrix Biol. 2019;78-79:100&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">29374576</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy N., Kuipers H.F., Marshall P.L., Wang E., Kaber G., Bollyky P.L. Hyaluronan in immune dysregulation and autoimmune diseases. Matrix Biol. 2019;78-79:292&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170738</ArticleId><ArticleId IdType="pubmed">29625181</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrey A.C., de la Motte C.A. Hyaluronan, a crucial regulator of inflammation. Front Immunol. 2014;5:101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3949149</ArticleId><ArticleId IdType="pubmed">24653726</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee-Sayer S.S.M., Dong Y.F., Arif A.A., Olsson M., Brown K.L., Johnson P. The where, when, how, and why of hyaluronan binding by immune cells. Front Immunol. 2015;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4396519</ArticleId><ArticleId IdType="pubmed">25926830</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldin P., Basu K., Kozlova I., Porsch H. HAS2 and CD44 in breast tumorigenesis. Adv Cancer Res. 2014;123:211&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">25081531</ArticleId></ArticleIdList></Reference><Reference><Citation>Turley E.A., Wood D.K., McCarthy J.B. Carcinoma cell Hyaluronan as a "portable" cancerized prometastatic microenvironment. Cancer Res. 2016;76(9):2507&#x2013;2512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4874571</ArticleId><ArticleId IdType="pubmed">27197262</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldin P., Pertoft H. Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp Cell Res. 1993;208:422&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">8375471</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldin P., Basu K., Olofsson B., Porsch H., Kozlova I., Kahata K. Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer. J Biochem. 2013;154(5):395&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">24092768</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242(1):27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9260563</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson W., Chow G., Knudson C.B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 2002;21(1):15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11827788</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent T.C., Laurent U.B.G., Fraser J.R.E. Serum hyaluronan as a disease marker. Ann Med. 1996;28(3):241&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">8811168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D.G., Prevo R., Clasper S., Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 2001;22(6):317&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">11377291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallisalmi M., Tenhunen J., Kultti A., Tammi M., Pettila V. Plasma hyaluronan and hemorheology in patients with septic shock: a clinical and experimental study. Clin Hemorheol Microcirc. 2014;56(2):133&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">23380965</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">17373886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolarova H., Ambruzova B., Sindlerova L.S., Klinke A., Kubala L. Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm. 2014;2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3997148</ArticleId><ArticleId IdType="pubmed">24803742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sussmann M., Sarbia M., Meyer-Kirchrath J., Nusing R.M., Schror K., Fischer J.W. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ Res. 2004;94(5):592&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">14752026</ArticleId></ArticleIdList></Reference><Reference><Citation>Homann S., Grandoch M., Kiene L.S., Podsvyadek Y., Feldmann K., Rabausch B. Hyaluronan synthase 3 promotes plaque inflammation and atheroprogression. Matrix Biol. 2018;66:67&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6023397</ArticleId><ArticleId IdType="pubmed">28987865</ArticleId></ArticleIdList></Reference><Reference><Citation>Olofsson B., Porsch H., Heldin P. Knock-down of CD44 regulates endothelial cell differentiation via NFkappaB-mediated chemokine production. PLoS One. 2014;9(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948721</ArticleId><ArticleId IdType="pubmed">24614402</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmanian M., Heldin P. Testicular hyaluronidase induces tubular structures of endothelial cells grown in three-dimensional collagen gel through a CD44-mediated mechanism. Int J Cancer. 2002;97(5):601&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">11807784</ArticleId></ArticleIdList></Reference><Reference><Citation>West D.C., Kumar S. Hyaluronan and angiogenesis. In: Evered D., Whelan J., editors. The biology of hyaluronan. Ciba Found. Symp. vol. 143. Wiley; Chichester: 1989. pp. 187&#x2013;201.</Citation></Reference><Reference><Citation>Medina C.O., Nagy N., Bollyky P.L. Extracellular matrix and the maintenance and loss of peripheral immune tolerance in autoimmune insulitis. Curr Opin Immunol. 2018;55:22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6286219</ArticleId><ArticleId IdType="pubmed">30248522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuipers H.F., Rieck M., Gurevich I., Nagy N., Butte M.J., Negrin R.S. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A. 2016;113(5):1339&#x2013;1344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4747722</ArticleId><ArticleId IdType="pubmed">26787861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushiyama A., Kataoka H., Iijima T. Glycocalyx and its involvement in clinical pathophysiologies. J Intensive Care. 2016;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5017018</ArticleId><ArticleId IdType="pubmed">27617097</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogne S., Flamion B., Caron N. Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases. Arterioscler Thromb Vasc Biol. 2018;38(7):1427&#x2013;1439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6039403</ArticleId><ArticleId IdType="pubmed">29880486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 2008;121(Pt 13):2115&#x2013;2122.</Citation><ArticleIdList><ArticleId IdType="pubmed">18565824</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvorak A.M., MacGlashan D.W., Jr., Morgan E.S., Lichtenstein L.M. Vesicular transport of histamine in stimulated human basophils. Blood. 1996;88(11):4090&#x2013;4101.</Citation><ArticleIdList><ArticleId IdType="pubmed">8943842</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Harris E. Dengue. Lancet. 2015;385(9966):453&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Modhiran N., Watterson D., Muller D.A., Panetta A.K., Sester D.P., Liu L.D. Dengue virus NS1 protein activates cells via toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med. 2015;7(304)</Citation><ArticleIdList><ArticleId IdType="pubmed">26355031</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon-Loriere E., Duong V., Tawfik A., Ung S., Ly S., Casademont I. Increased adaptive immune responses and proper feedback regulation protect against clinical dengue. Sci Transl Med. 2017;9(405)</Citation><ArticleIdList><ArticleId IdType="pubmed">28855396</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb Haemost. 2009;102(6):1042&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5527705</ArticleId><ArticleId IdType="pubmed">19967133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.R., Chuang Y.C., Lin Y.S., Liu H.S., Liu C.C., Perng G.C. Dengue virus nonstructural protein 1 induces vascular leakage through macrophage migration inhibitory factor and autophagy. Plos Neglect Trop D. 2016;10(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4943727</ArticleId><ArticleId IdType="pubmed">27409803</ArticleId></ArticleIdList></Reference><Reference><Citation>Puerta-Guardo H., Glasner D.R., Harris E. Dengue virus NS1 disrupts the endothelial Glycocalyx, leading to hyperpermeability. PLoS Pathog. 2016;12(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944995</ArticleId><ArticleId IdType="pubmed">27416066</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner D.R., Ratnasiri K., Puerta-Guardo H., Espinosa D.A., Beatty P.R., Harris E. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathog. 2017;13(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679539</ArticleId><ArticleId IdType="pubmed">29121099</ArticleId></ArticleIdList></Reference><Reference><Citation>Balazs E.A., Darzynskiewicz Z., Kulonen E., Pikkarainen J. Academic Press; New York: 1973. The effect of hyaluronic acid on fibroblasts, mononuclear phagocytes and lymphocytes; pp. 237&#x2013;252.</Citation></Reference><Reference><Citation>Puerta-Guardo H., Glasner D.R., Espinosa D.A., Biering S.B., Patana M., Ratnasiri K. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 2019;26(6):1598&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6934102</ArticleId><ArticleId IdType="pubmed">30726741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.F., Chang K., Lu R.W., Wang W.H., Chen Y.H., Chen M. Large dengue virus type 1 outbreak in Taiwan. Emerg Microbes Infec. 2015;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576165</ArticleId><ArticleId IdType="pubmed">26421269</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.F., Chang K., Loh E., Wang W.H., Tseng S.P., Lu P.L. Consecutive large dengue outbreaks in Taiwan in 2014-2015. Emerg Microbes Infec. 2016;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5180368</ArticleId><ArticleId IdType="pubmed">27924810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K., Huang C.H., Lee I.K., Lu P.L., Lin C.Y., Chen T.C. Differences in mortality and clinical manifestations of dengue Hemorrhagic fever in Taiwan in different years: a comparison for cases in 2014 and 2015 epidemics. American JTropical Med Hygiene. 2017;97(2):361&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544090</ArticleId><ArticleId IdType="pubmed">28722609</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T.H., Alonso S., Ng L.F., Thein T.L., Pang V.J., Leo Y.S. Increased serum hyaluronic acid and Heparan Sulfate in dengue fever: association with plasma leakage and disease severity. Sci Rep. 2017;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5385535</ArticleId><ArticleId IdType="pubmed">28393899</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Asteriou T., Bernert B., Heldin C.H., Heldin P. Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J. 2007;404(2):327&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868797</ArticleId><ArticleId IdType="pubmed">17324121</ArticleId></ArticleIdList></Reference><Reference><Citation>Venetsanakos E., Mirza A., Fanton C., Romanov S.R., Tlsty T., McMahon M. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res. 2002;273(1):21&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">11795943</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson A., Rahmanian M., Rubin K., Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer. 2002;102:212&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">12397638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalkanen S., Bargatze R.F., de los Toyos J., ECs Butcher. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kDa glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol. 1987;105:983&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2114763</ArticleId><ArticleId IdType="pubmed">2442176</ArticleId></ArticleIdList></Reference><Reference><Citation>Park E.K., Jung H.S., Yang H.I., Yoo M.C., Kim C., Kim K.S. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56(1):45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17334670</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff I., Hornburger M.C., Mayer B.A., Beyerle A., Wegener J., Furst R. Pitfalls in assessing microvascular endothelial barrier function: impedance-based devices versus the classic macromolecular tracer assay. Sci Rep-Uk. 2016;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4877919</ArticleId><ArticleId IdType="pubmed">27025965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo K., Nakamura T., Takagaki K., Yoshida Y., Endo M. Depolymerization of hyaluronan by sonication. Glycoconj J. 1993;10(6):435&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">8173334</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavianatou A., Piperigkou Z., Barbera C., Beninatto R., Masola V., Caon I. Molecular size-dependent specificity of hyaluronan on functional properties,morphology and matrix composition of mammary cancer cells. Matrix Biol. 2019;3:1&#x2013;24.</Citation></Reference><Reference><Citation>Rahbar E., Cardenas J.C., Baimukanova G., Usadi B., Bruhn R., Pati S. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med. 2015;13:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4397670</ArticleId><ArticleId IdType="pubmed">25889764</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwarto S., Sasmono R.T., Sinto R., Ibrahim E., Suryamin M. Association of endothelial glycocalyx and tight and adherens junctions with severity of plasma leakage in dengue infection. J Infect Dis. 2017;215(6):992&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407050</ArticleId><ArticleId IdType="pubmed">28453844</ArticleId></ArticleIdList></Reference><Reference><Citation>Porsch H., Bernert B., Mehic M., Theocharis A.D., Heldin C.H., Heldin P. Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene. 2013;32(37):4355&#x2013;4365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3778714</ArticleId><ArticleId IdType="pubmed">23108409</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigetti D., Genasetti A., Karousou E., Viola M., Moretto P., Clerici M. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-kappaB (NF-kappaB) pathway. J Biol Chem. 2010;285(32):24639&#x2013;24645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2915700</ArticleId><ArticleId IdType="pubmed">20522558</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuneki M., Madri J.A. CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression. J Biol Chem. 2014;289(9):5357&#x2013;5370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937614</ArticleId><ArticleId IdType="pubmed">24425872</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerutti C., Ridley A.J. Endothelial cell-cell adhesion and signaling. Exp Cell Res. 2017;358(1):31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5700119</ArticleId><ArticleId IdType="pubmed">28602626</ArticleId></ArticleIdList></Reference><Reference><Citation>Allonso D., Meneses M.D.F., Fernandes C.A., Ferreira D.F., Mohana-Borges R. Assessing positivity and circulating levels of NS1 in samples from a 2012 dengue outbreak in Rio de Janeiro, Brazil. Plos One. 2014;9(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4239100</ArticleId><ArticleId IdType="pubmed">25412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liu J.Y., Cheng G. Vaccines and immunization strategies for dengue prevention. Emerg Microbes Infec. 2016;5</Citation></Reference><Reference><Citation>Simmons C.P., Farrar J.J., Nguyen v V., Wills B. Dengue. N Engl J Med. 2012;366(15):1423&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Honsawek S., Kongtawelert P., Pothacharoen P., Khongphatthanayothin A., Chongsrisawat V., Poovorawan Y. Increased levels of serum hyaluronan in patients with dengue infection. J Infect. 2007;54(3):225&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">16876870</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavey M., Rauzi M., Lenne P.F., Lecuit T. A two-tiered mechanism for stabilization and immobilization of E-cadherin. Nature. 2008;453(7196):751&#x2013;U2.</Citation><ArticleIdList><ArticleId IdType="pubmed">18480755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E., Tournier-Lasserve E., Weinstein B.M. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell. 2009;16(2):209&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">19217423</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarris B.J., Fraser J.R.E., Rodda S.J. Effect of cell-bound hyaluronic acid on infectivity of Newcastle disease virus for human synovial cells in vitro. Ann Rheum Dis. 1974;33:240&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1006248</ArticleId><ArticleId IdType="pubmed">4843131</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Motte C.A., Hascall V.C., Drazba J., Bandyopadhyay S.K., Strong S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol. 2003;163(1):121&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868154</ArticleId><ArticleId IdType="pubmed">12819017</ArticleId></ArticleIdList></Reference><Reference><Citation>Culty M., Nguyen H.A., Underhill C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol. 1992;116:1055&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289343</ArticleId><ArticleId IdType="pubmed">1370836</ArticleId></ArticleIdList></Reference><Reference><Citation>Teder P., Heldin P. Mechanism of impaired local hyaluronan turnover in bleomycin-induced lung injury in rat. Am J Respir Cell Mol Biol. 1997;17:376&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">9308925</ArticleId></ArticleIdList></Reference><Reference><Citation>Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Pure E. Resolution of lung inflammation by CD44. Science. 2002;296(5565):155&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">11935029</ArticleId></ArticleIdList></Reference><Reference><Citation>Levesque M.C., Haynes B.F. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J Immunol. 1997;159(12):6184&#x2013;6194.</Citation><ArticleIdList><ArticleId IdType="pubmed">9550421</ArticleId></ArticleIdList></Reference><Reference><Citation>Duterme C., Mertens-Strijthagen J., Tammi M., Flamion B. Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions. J Biol Chem. 2009;284(48):33495&#x2013;33508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785194</ArticleId><ArticleId IdType="pubmed">19783662</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.L., Duh F.M., Lerman M.I., Miller A.D. Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus Env proteins. J Virol. 2003;77(5):2850&#x2013;2858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC149765</ArticleId><ArticleId IdType="pubmed">12584308</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley A.C., Oltean S., Hascall V., Woods E.L., Steadman R., Phillips A.O. Nuclear hyaluronidase 2 drives alternative splicing of CD44 pre-mRNA to determine profibrotic or antifibrotic cell phenotype. Sci Signal. 2017;10(506)</Citation><ArticleIdList><ArticleId IdType="pubmed">29162741</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H., Nagaoka A., Kusaka-Kikushima A., Tobiishi M., Kawabata K., Sayo T. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc Natl Acad Sci U S A. 2013;110(14):5612&#x2013;5617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3619336</ArticleId><ArticleId IdType="pubmed">23509262</ArticleId></ArticleIdList></Reference><Reference><Citation>De Angelis J.E., Lagendijk A.K., Chen H.J., Tromp A., Bower N.I., Tunny K.A. Tmem2 regulates embryonic Vegf signaling by controlling hyaluronic acid turnover. Dev Cell. 2017;40(2):123&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">28118600</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogne S., Rath G., Jouret F., Caron N., Dessy C., Flamion B. Hyaluronidase 1 deficiency preserves endothelial function and Glycocalyx integrity in early Streptozotocin-induced diabetes. Diabetes. 2016;65(9):2742&#x2013;2753.</Citation><ArticleIdList><ArticleId IdType="pubmed">27246914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X.Q., Chena L., Yea P., Wang Z.M., Zhang J.J., Ye F. The role of HYAL2 in LSS-induced glycocalyx impairment and the PKA-mediated decrease in eNOS-Ser-633 phosphorylation and nitric oxide production. Mol Biol Cell. 2016;27(25):3972&#x2013;3979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5156538</ArticleId><ArticleId IdType="pubmed">27798230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey N., Jain A., Garg R.K., Kumar R., Agrawal O.P., Lakshmana Rao P.V. Serum levels of IL-8, IFNgamma, IL-10, and TGF beta and their gene expression levels in severe and non-severe cases of dengue virus infection. Arch Virol. 2015;160(6):1463&#x2013;1475.</Citation><ArticleIdList><ArticleId IdType="pubmed">25860648</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.C., Hofman F.M., Kung J.T., Lin Y.D., Wu-Hsieh B.A. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81(11):5518&#x2013;5526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900309</ArticleId><ArticleId IdType="pubmed">17360740</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D.H., Liang J.R., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91(1):221&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3051404</ArticleId><ArticleId IdType="pubmed">21248167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert S.M., Hawn T.R., Arrigoni A., Wight T.N., Bollyky P.L. Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res. 2014;58(2&#x2013;3):186&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106675</ArticleId><ArticleId IdType="pubmed">24614953</ArticleId></ArticleIdList></Reference><Reference><Citation>Beatty P.R., Puerta-Guardo H., Killingbeck S.S., Glasner D.R., Hopkins K., Harris E. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med. 2015;7(304)</Citation><ArticleIdList><ArticleId IdType="pubmed">26355030</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>